Ischemin (sodium)
Ischemin sodium is a CBP bromodomain inhibitor that inhibits p53 interaction with CBP and transcriptional activity in cells. Ischemin sodium salt inhibits p53-induced p21 activation with an IC50 value of 5 µM. Ischemin sodium salt also prevents apoptosis in ischemic cardiomyocytes. Ischemin sodium salt can be used in the study of cardiovascular diseases (such as myocardial ischemia) [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; Epigenetic Reader Domain; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis; Epigenetics
Applications
Neuroscience-Neurodegeneration
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/ischemin-sodium.html
Purity
99.32
Solubility
H2O : 25 mg/mL (ultrasonic)
Smiles
CC1=CC(/N=N/C2=C(C=C(C(S(=O)(O[Na])=O)=C2)C)C)=C(C=C1O)N
Molecular Formula
C15H16N3NaO4S
Molecular Weight
357.36
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) (rCD30/412), CF488A conjugate, 0.1mg/mL
Cytokeratin, pan (AE-1 / AE-3), CF640R conjugate, 0.1mg/mL
